Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Royal Philips    PHIA   NL0000009538

ROYAL PHILIPS

(PHIA)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

PHILIPS : and Georgia Regents Medical Center sign a 15-year alliance to facilitate innovative and affordable care

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/28/2013 | 01:13am EST


  • Healthcare industry-defining model to improve patient outcomes and reduce costs through new technologies, operational planning, support and consulting services
  • Long term alliance will support multiple GRMC sites, including its combined 632-bed medical center, cancer center, and children's hospital, with an order value of approximately USD 300 million


Andover, MA and Augusta, GA - Royal Philips (NYSE: PHG, AEX: PHIA) and Georgia Regents Medical Center (GRMC), Georgia's public academic health center renowned for its top-ranked doctors, today announced a 15-year alliance to enable increasingly patient-centered approaches to care and to create an innovative business model that addresses current and future clinical, operational and equipment needs of GRMC's multiple sites.

The alliance is a first-of-its-kind delivery model in the United States. Through the agreement, worth approximately USD 300 million, the largest of its kind for Philips, the company will provide GRMC with a comprehensive range of consulting services, advanced medical technologies, and operational performance, planning and maintenance services with pre-determined monthly operational costs over a 15-year term.

The alliance will broadly support the Georgia Regents Medical Center, Children's Hospital of Georgia, Georgia Regents University Cancer Center and the health system's numerous outpatient clinics, which serve the medical needs of four to six million people, across Georgia and South Carolina. Philips and Georgia Regents will work closely to deliver faster, more effective and cost-efficient care from diagnostics to therapeutics, and inpatient and outpatient clinical services. The alliance will impact all care areas, including radiology, cardiology, neurology, oncology and pediatrics, and enhance medical research and clinical technology R&D initiatives for care delivery innovation.

The agreement encompasses Philips imaging systems, patient monitoring and clinical informatics solutions, as well as lighting and consumer products. Philips will also furnish GRMC rapid access to new equipment as well as educational resources. Philips and GRMC will work together to cost-effectively design and deploy innovative patient care strategies.

"By collaborating with Philips, we're bringing all the stakeholders together at the same table to better assess and plan health care for tomorrow. It's no longer a simple supply-and-demand business model," said David S. Hefner, Chief Executive Officer for Georgia Regents Medical Center. "Our goal is to foster an atmosphere of meaningful innovation that will have a significant and positive impact on the health of our patients."

"We are proud to embark on this transformational alliance with Georgia Regents Medical Center as we share the vision that we can create the future of health care by creatively and cost-effectively meeting the long-term needs of patients," said Deborah DiSanzo, chief executive officer, Philips Healthcare."

With more than 100 years of experience in health care, Philips' aim is to provide innovative solutions that address the complexities of health care delivery by working in close partnership with healthcare providers. The long term alliance with GRMC in the U.S. follows collaborations with hospitals in Europe, Asia, the Middle-east and Africa that have resulted in improved clinical operations and care delivery performance.



distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ROYAL PHILIPS
12/05Philips and Paige team up to bring Artificial Intelligence (AI) to clinical p..
GL
12/04ROYAL PHILIPS : Philips and Humana team up to improve care for at-risk Medicare ..
AQ
12/03ROYAL PHILIPS : Philips drives transition to the circular economy at RSNA 2019
PU
12/03ROYAL PHILIPS : Philips and Inspira Health announce USD 50 million, long-term st..
AQ
12/03ROYAL PHILIPS : Philips and Dutch change makers meet to discuss circular efforts
PU
12/02ROYAL PHILIPS : Philips and Inspira Health Announce $50 Million, Long-term Strat..
BU
12/02Philips demonstrates innovation leadership in MR at RSNA
GL
12/02Philips and Inspira Health announce USD 50 million, long-term strategic partn..
GL
12/02ROYAL PHILIPS : Philips joins AMSUS Executive Advisory Board to help innovate ca..
BU
12/01Philips highlights AI-powered solutions focus to realize precision diagnosis ..
GL
More news
Financials (EUR)
Sales 2019 19 481 M
EBIT 2019 2 392 M
Net income 2019 1 319 M
Debt 2019 3 238 M
Yield 2019 2,03%
P/E ratio 2019 30,0x
P/E ratio 2020 23,4x
EV / Sales2019 2,13x
EV / Sales2020 2,01x
Capitalization 38 198 M
Chart ROYAL PHILIPS
Duration : Period :
Royal Philips Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL PHILIPS
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 44,44  €
Last Close Price 42,61  €
Spread / Highest target 26,5%
Spread / Average Target 4,30%
Spread / Lowest Target -17,9%
EPS Revisions
Managers
NameTitle
Frans van Houten Chief Executive Officer
Jeroen van der Veer Chairman-Supervisory Board
Sophie Bechu Chief Operating Officer & Executive Vice President
Abhijit Bhattacharya Chief Financial Officer & Executive Vice President
Jan Kimpen Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL PHILIPS37.76%42 208
THERMO FISHER SCIENTIFIC43.04%128 365
DANAHER CORPORATION43.74%106 733
INTUITIVE SURGICAL, INC.22.27%67 676
BOSTON SCIENTIFIC CORPORATION24.73%61 440
EDWARDS LIFESCIENCES CORPORATION56.02%49 844